Ignite Creation Date:
2024-05-05 @ 11:25 PM
Last Modification Date:
2024-10-26 @ 10:33 AM
Study NCT ID:
NCT01323699
Status:
COMPLETED
Last Update Posted:
2013-05-01
First Post:
2011-03-25
Brief Title:
Behavioral Treatments for Anxiety and Depression in Veterans With Parkinsons Disease
Sponsor:
Michael E DeBakey VA Medical Center
Organization:
Michael E DeBakey VA Medical Center
Study Overview
Official Title:
Increasing Access and Implementation of Behavioral Treatments for Anxiety and Depression in Rural Veterans With Parkinsons Disease
Status:
COMPLETED
Status Verified Date:
2013-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
BehTA-D
Brief Summary:
Behavioral Treatments for Anxiety and Depression BehTA-D is a research study for anxiety and depression in individuals with Parkinsons disease PD The research clinicians try to teach skills that may help participants cope with anxiety and depression in the context of Parkinsons disease Research clinicians will also discuss ways improve management of Parkinsons symptoms Other skills taught include how to relax change thinking add in meaningful pleasant activity
Detailed Description:
Components of evidence-based cognitive behavioral therapy CBT treatments from current manuals developed for depression and anxiety will be used to construct the 8-week treatment program The flexibility of modular based treatment allows patients and counselors to personalize interventions and skills for managing anxiety and depressive symptoms The first treatment session will be in-person All following sessions will be provided by telephone Caregivers will have the option of being involved in 2 ways throughout treatment - as a coach to facilitate use of new skills by their loved one with PD and as a recipient of stress- management support The scope of caregiver involvement will vary across patients based on their preference Involved caregivers will be given the opportunity to participate in 1 telephone-based stress-management session and 1 follow-up call scheduled individually during the first 4 weeks of treatment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None